The Leukemia & Lymphoma Society Announces Appointment of New President and CEO

John Walter, with LLS Since 1995, Tapped to Steer the World's Largest

Organization Dedicated to Blood Cancer Research and Patient Services

Apr 10, 2008, 01:00 ET from The Leukemia & Lymphoma Society

    WHITE PLAINS, N.Y., April 10 /PRNewswire/ -- The Leukemia & Lymphoma
 Society has appointed John Walter as its president and chief executive
 officer, with the task of leading the world's largest organization
 dedicated to funding blood cancer research as it strives to find cures and
 prolong and enhance the lives of patients with leukemia, lymphoma and
     (Photo: )
     Walter, who has been with LLS since 1995, most recently as chief
 operating officer, succeeds Dwayne Howell, Ph.D., who retired in February.
     "After conducting a nationwide search, the LLS Board of Directors
 agreed that John Walter was the best candidate to steer us as we move
 toward achieving our mission of curing blood cancers and improving the
 lives of patients and their families," said LLS Chairman David Frantze.
 "The Leukemia & Lymphoma Society is a $300 million plus organization
 committed to identifying the best scientists in the world in the field of
 blood cancer research and providing the funding to help them find cures and
 better therapies. In John, we have somebody at the helm with the vision and
 leadership qualities to provide support for our patients in their journey
 dealing with these devastating diseases."
     Walter started his career at LLS as senior vice president of finance
 and information technology, during which time he enhanced the efficiencies
 and internal controls of the organization by centralizing all finance and
 treasury operations in the United States and Canada. He also established
 LLS's information technology and Web functions.
     He served as chief financial officer, and then, as executive vice
 president, strategic alliances and new business development he designed and
 implemented LLS's Co-Pay Assistance Program, a service that helps blood
 cancer patients with their health insurance premiums and prescription drug
     He came to LLS from the March of Dimes, where he worked for nine years.
 He had previously worked at Donaldson, Lufkin & Jenrette and at
 Bristol-Myers Squibb, where he had broad international experience.
     About The Leukemia & Lymphoma Society
     The Leukemia & Lymphoma Society(R), headquartered in White Plains, NY,
 with 68 chapters in the United States and Canada, is the world's largest
 voluntary health organization dedicated to funding blood cancer research
 and providing education and patient services. The LLS mission: Cure
 leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality
 of life of patients and their families. Since its founding in 1949, LLS has
 invested more than $550 million in research specifically targeting
 leukemia, lymphoma and myeloma. Last year alone, LLS made 5.1 million
 contacts with patients, caregivers and healthcare professionals.
     For more information about blood cancer, visit or call the
 LLS Information Resource Center (IRC), a call center staffed by master's
 level social workers, nurses and health educators who provide information,
 support and resources to patients and their families and caregivers. IRC
 information specialists are available at (800) 955-4572, Monday through
 Friday, 9 a.m. to 6 p.m. ET.
     Contact: Andrea Greif

SOURCE The Leukemia & Lymphoma Society